239 related articles for article (PubMed ID: 12459592)
1. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.
Messaoudi I; Guevara Patiño JA; Dyall R; LeMaoult J; Nikolich-Zugich J
Science; 2002 Nov; 298(5599):1797-800. PubMed ID: 12459592
[TBL] [Abstract][Full Text] [Related]
2. Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytes.
Leggatt GR; Narayan S; Fernando GJ; Frazer IH
J Leukoc Biol; 2004 Oct; 76(4):787-95. PubMed ID: 15240746
[TBL] [Abstract][Full Text] [Related]
3. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
[TBL] [Abstract][Full Text] [Related]
4. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
[TBL] [Abstract][Full Text] [Related]
6. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
[TBL] [Abstract][Full Text] [Related]
7. Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B.
Jones CM; Cose SC; Carbone FR
Int Immunol; 1997 Sep; 9(9):1319-28. PubMed ID: 9310835
[TBL] [Abstract][Full Text] [Related]
8. A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo.
Carey B; DeLay M; Strasser JE; Chalk C; Dudley-McClain K; Milligan GN; Brunner HI; Thornton S; Hirsch R
Clin Immunol; 2005 Jul; 116(1):65-76. PubMed ID: 15925833
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
Gorgian Mohammadi M; Bamdad T; Parsania M; Hashemi HR; Puyanfard S
Iran J Immunol; 2009 Mar; 6(1):22-7. PubMed ID: 19293474
[TBL] [Abstract][Full Text] [Related]
11. Structural changes in class I MHC molecules influencing recognition by allo- or self + TNP-reactive cytotoxic T-cell clones and by monoclonal antibodies.
Davignon JL; Albert F; Boyer C; Hua C; Buferne M; Guimezanes A; Schmitt-Verhulst AM
Transplant Proc; 1983 Dec; 15(4):2080-5. PubMed ID: 6608811
[No Abstract] [Full Text] [Related]
12. Identification of MHC class I H-2 Kb/Db-restricted immunogenic peptides derived from retinal proteins.
Wang M; Bai F; Pries M; Buus S; Prause JU; Nissen MH
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3939-45. PubMed ID: 16936108
[TBL] [Abstract][Full Text] [Related]
13. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
Rich RF; Cook WJ; Green WR
Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
[TBL] [Abstract][Full Text] [Related]
16. Genetic and regulatory contributions of the major histocompatibility complex to the developing cytolytic T lymphocyte repertoire.
Sherman LA
J Immunol; 1982 Apr; 128(4):1849-53. PubMed ID: 7061852
[TBL] [Abstract][Full Text] [Related]
17. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
18. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity.
Moraru M; Cisneros E; Gómez-Lozano N; de Pablo R; Portero F; Cañizares M; Vaquero M; Roustán G; Millán I; López-Botet M; Vilches C
J Immunol; 2012 May; 188(9):4412-20. PubMed ID: 22490439
[TBL] [Abstract][Full Text] [Related]
19. Effects of the major histocompatibility complex loci and T-cell receptor beta-chain repertoire on Theiler's virus-induced demyelinating disease.
Kim BS; Mohindru M; Kang B; Kang HS; Palma JP
J Neurosci Res; 2005 Sep; 81(6):846-56. PubMed ID: 16049971
[TBL] [Abstract][Full Text] [Related]
20. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex.
Rubin B; Riond J; Leghait J; Gairin JE
Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
